Cargando…
Structure-Based Discovery and Bioactivity Evaluation of Novel Aurora-A Kinase Inhibitors as Anticancer Agents via Docking-Based Comparative Intermolecular Contacts Analysis (dbCICA)
Aurora-A kinase plays a central role in mitosis, where aberrant activation contributes to cancer by promoting cell cycle progression, genomic instability, epithelial-mesenchymal transition, and cancer stemness. Aurora-A kinase inhibitors have shown encouraging results in clinical trials but have not...
Autores principales: | Hijjawi, Majd S., Abutayeh, Reem Fawaz, Taha, Mutasem O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766225/ https://www.ncbi.nlm.nih.gov/pubmed/33353031 http://dx.doi.org/10.3390/molecules25246003 |
Ejemplares similares
-
Pharmacophore Mapping Combined with dbCICA Reveal New Structural Features for the Development of Novel Ligands Targeting α4β2 and α7 Nicotinic Acetylcholine Receptors
por: Batista, Victor S., et al.
Publicado: (2022) -
Computer, Informatics, Cybernetics and Applications : Proceedings of the CICA 2011
por: He, Xingui, et al.
Publicado: (2012) -
Discovery of new STAT3 inhibitors as anticancer agents using ligand-receptor contact fingerprints and docking-augmented machine learning
por: Jaradat, Nour Jamal, et al.
Publicado: (2023) -
Docking-generated multiple ligand poses for bootstrapping bioactivity classifying Machine Learning: Repurposing covalent inhibitors for COVID-19-related TMPRSS2 as case study
por: Hatmal, Ma'mon M., et al.
Publicado: (2021) -
The Discovery of Aurora Kinase Inhibitor by Multi-Docking-Based Virtual Screening
por: Kim, Jun-Tae, et al.
Publicado: (2014)